Integer Holdings Co. (NYSE:ITGR) Shares Acquired by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. raised its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 33.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,516 shares of the medical equipment provider's stock after acquiring an additional 2,384 shares during the quarter. D. E. Shaw & Co. Inc.'s holdings in Integer were worth $1,261,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ITGR. KBC Group NV grew its stake in Integer by 83.3% in the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after purchasing an additional 726 shares in the last quarter. Tributary Capital Management LLC lifted its holdings in Integer by 0.8% during the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock worth $38,103,000 after buying an additional 2,289 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in Integer by 3.9% during the 4th quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock worth $24,154,000 after buying an additional 6,905 shares during the last quarter. Laurus Investment Counsel Inc. acquired a new position in shares of Integer in the 4th quarter worth approximately $5,422,000. Finally, Congress Asset Management Co. increased its holdings in shares of Integer by 2.0% in the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after acquiring an additional 9,565 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Stock Performance

Integer stock traded down $1.76 during mid-day trading on Wednesday, hitting $119.87. 21,260 shares of the company's stock traded hands, compared to its average volume of 371,648. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36. The firm has a 50 day moving average price of $118.47 and a 200 day moving average price of $128.95. The company has a market cap of $4.18 billion, a PE ratio of 35.75, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 earnings per share. On average, equities analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Insider Transactions at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares of the company's stock, valued at approximately $5,788,990. The trade was a 87.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.16% of the company's stock.

Analyst Ratings Changes

ITGR has been the topic of several research analyst reports. KeyCorp reduced their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Raymond James upped their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, April 25th. Truist Financial set a $150.00 price target on Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and increased their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Integer currently has an average rating of "Moderate Buy" and a consensus price target of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.